interferon gamma drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (9)
Papers in which this entity is mentioned.
- Modeling heterogeneity in single-cell perturbation states enhances detection of response eQTLs. (2025)
- Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
- Chromosomal instability as a driver of cancer progression. (2025)
- Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy. (2024)
- ENPP1 Immunobiology as a Therapeutic Target. (2023)
- B cells and tertiary lymphoid structures promote immunotherapy response. (2020)
- B lymphocytes and cancer: a love-hate relationship. (2016)
- Effects of alcohol on the endocrine system. (2013)
- Myeloid cells in tumor inflammation. (2012)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ifnγ | drug | 22 | 63 |
| interferon gamma | drug | 9 | 11 |